Datasets:

Suchinthana
/

support2-1

Dataset card Data Studio Files Files and versions Community

Split (1)

train · 9.11k rows

ID int64 1 9.11k	age float64 18 102	death int64 0 1	sex stringclasses 2 values	hospdead int64 0 1	slos int64 3 343	d.time int64 3 2.03k	dzgroup stringclasses 8 values	dzclass stringclasses 4 values	num.co int64 0 9	edu float64 0 31 ⌀	income stringclasses 4 values	scoma float64 0 100 ⌀	charges float64 1.17k 1.44M ⌀	totcst float64 0 633k ⌀	totmcst float64 -102.72 711k ⌀	avtisst float64 1 83 ⌀	race stringclasses 5 values	sps float64 0.2 99.2 ⌀	aps float64 0 143 ⌀	surv2m float64 0 0.97 ⌀	surv6m float64 0 0.95 ⌀	hday int64 1 148	diabetes int64 0 1	dementia int64 0 1	ca stringclasses 3 values	prg2m float64 0 1 ⌀	prg6m float64 0 1 ⌀	dnr stringclasses 3 values	dnrday float64 -88 285 ⌀	meanbp float64 0 195 ⌀	wblc float64 0 200 ⌀	hrt float64 0 300 ⌀	resp float64 0 90 ⌀	temp float64 31.7 41.7 ⌀	pafi float64 12 890 ⌀	alb float64 0.4 29 ⌀	bili float64 0.1 63 ⌀	crea float64 0.1 21.5 ⌀	sod float64 110 181 ⌀	ph float64 6.83 7.77 ⌀	glucose float64 0 1.09k ⌀	bun float64 1 300 ⌀	urine float64 0 9k ⌀	adlp float64 0 7 ⌀	adls float64 0 7 ⌀	sfdm2 stringclasses 5 values	adlsc float64 0 7.07
7,001	68.112	1	female	0	25	27	Lung Cancer	Cancer	5	null	null	9	25,699	18,062.3438	22,461.6875	11.25	white	34.09375	28	0.197998	0.017998	1	0	0	metastatic	0.4	0.1	dnr after sadm	6	79	100	70	22	37.5	319	3.799805	1	1.299805	142	7.479492	84	21	null	null	null	<2 mo. follow-up	5.183594
7,002	68.67096	1	female	0	37	86	Coma	Coma	2	12	under $11k	44	100,640	66,801.3125	76,272.625	33.5	white	21.296875	40	0.32196	0.25	21	1	0	yes	0.6	0.4	no dnr	37	77	5	60	20	36.5	null	2	7.899414	0.899902	126	null	289	11	2,606	null	6	adl>=4 (>=5 if sur)	6
7,003	67.97797	1	female	1	5	5	CHF	COPD/CHF/Cirrhosis	1	8	null	37	68,460	43,711.4062	50,218.5	44	white	19.796875	32	0.689941	0.523926	18	0	0	no	0.75	0.6	no dnr	5	122	6.799805	195	38	38.39844	176.65625	2.799805	0.599976	0.799927	135	7.359375	99	11	1,565	null	null	<2 mo. follow-up	2.545898
7,004	59.73999	1	male	0	10	12	Lung Cancer	Cancer	2	12	$25-$50k	0	8,042	6,030.7617	7,824.15625	13.5	white	30.5	17	0.375977	0.087997	1	0	0	metastatic	0.1	0	dnr after sadm	1	136	18.898438	111	8	39.69531	148	3	0.699951	1.099854	146	7.489258	139	7	1,366	null	6	<2 mo. follow-up	6
7,005	69.383	1	female	1	112	112	ARF/MOSF w/Sepsis	ARF/MOSF	0	4	under $11k	0	435,766	293,525	354,347.25	27.75	hispanic	30	35	0.563965	0.451965	140	0	0	no	0.9	0.9	dnr after sadm	109	73	6.099609	76	24	35	null	3.299805	1.599854	1.5	143	null	45	33	null	null	0	adl>=4 (>=5 if sur)	0
7,006	78.51294	1	female	0	21	58	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	37	30,168	20,644.1094	25,320.375	31	white	33.195313	48	0.367981	0.25	1	0	0	no	0.5	0.2	dnr after sadm	3	64	12.599609	120	32	36.5	240	2.399902	0.5	5.299805	130	7.339844	162	69	1,079	null	null	<2 mo. follow-up	3.983887
7,007	69.16595	1	female	0	15	376	COPD	COPD/CHF/Cirrhosis	3	12	under $11k	0	31,257	20,410.9219	24,307.25	24.666656	white	34.695313	49	0.492981	0.290955	7	0	0	no	0.8	0.8	no dnr	15	116	6.899414	114	8	36.19531	136	3	1.099854	2	144	7.40918	206	28	4,115	0	2	SIP>=30	2
7,008	84.27899	1	female	0	54	65	ARF/MOSF w/Sepsis	ARF/MOSF	0	7	under $11k	41	68,870	47,045.5	55,787.3125	26	white	32.796875	71	0.289978	0.179993	2	0	0	no	0.5	0.1	dnr after sadm	47	101	6	66	22	36.39844	null	3.599609	0.899902	2	141	null	123	18	null	null	1	null	1
7,009	76.36395	0	female	0	73	890	ARF/MOSF w/Sepsis	ARF/MOSF	1	10	null	0	119,087	79,334.5625	92,289.6875	43.25	white	21	21	0.796997	0.730957	2	0	0	no	0.8	0.8	no dnr	73	56	20.898438	132	36	40	231.40625	1.299805	0.899902	0.799927	143	7.349609	134	15	2,505	null	2	adl>=4 (>=5 if sur)	2
7,010	72.57794	1	female	0	5	379	MOSF w/Malig	ARF/MOSF	3	10	under $11k	0	6,049	4,106	4,960.94922	18	white	29.097656	29	0.484985	0.365967	1	1	0	metastatic	0.5	0.3	dnr before sadm	-1	60	14.599609	113	28	38.79688	324	2	3.099609	0.899902	137	7.419922	153	33	3.959961	4	2	adl>=4 (>=5 if sur)	2
7,011	75.30695	0	female	0	9	887	ARF/MOSF w/Sepsis	ARF/MOSF	3	13	under $11k	0	9,566	6,663.5625	7,227.83984	11.5	white	28.097656	32	0.694946	0.603882	1	1	0	no	0.9	0.7	no dnr	9	132	14.699219	119	24	36.19531	233.3125	null	null	1	133	7.439453	159	19	2,770	1	2	adl>=4 (>=5 if sur)	2
7,012	69.05695	0	male	0	13	886	Cirrhosis	COPD/CHF/Cirrhosis	2	5	under $11k	0	12,084	8,825.9062	10,777.8047	8.5	white	16.898438	31	0.786987	0.657959	1	0	0	no	0.8	0.8	no dnr	13	52	10.599609	173	38	37.5	142	2	1.799805	1.799805	135	7.449219	181	29	2,810	null	0	no(M2 and SIP pres)	0
7,013	41.89697	1	male	0	18	576	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$11-$25k	0	41,054	28,431.0625	32,080.2188	18.333328	white	24.796875	42	0.817993	0.756958	15	0	0	no	0.5	0.5	no dnr	18	85	3.199707	77	20	36.39844	null	2.299805	0.699951	1.199951	135	null	153	38	1,660	0	1	SIP>=30	1
7,014	74.69995	1	female	1	40	40	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	null	0	38,627	27,789.3906	28,880.125	14.5	white	18.5	36	0.8479	0.795898	1	0	0	no	0.1	0.1	dnr after sadm	1	126	11.699219	111	29	36.19531	162.84375	3.599609	0.5	2.099609	136	7.449219	280	41	1.019775	null	4	<2 mo. follow-up	4
7,015	42.13599	0	male	0	13	885	ARF/MOSF w/Sepsis	ARF/MOSF	2	8	under $11k	0	28,696	18,141.125	21,220.9688	37	white	25.5	48	0.855957	0.805908	1	0	0	no	0.4	0.4	no dnr	13	117	13.199219	124	34	39.09375	150	2.399902	0.699951	1.299805	133	7.399414	204	14	2,510	null	0	no(M2 and SIP pres)	0
7,016	55.737	1	male	0	7	812	Colon Cancer	Cancer	1	24	>$50k	0	14,069	9,302.2656	10,124.6328	15	white	9.099609	27	0.908936	0.78894	1	0	0	metastatic	1	0.9	no dnr	7	61	18	116	25	36.59375	266.625	1.699951	1.099854	2.199707	129	7.339844	71	120	1,380	1	null	null	1.166748
7,017	68.50897	1	male	0	11	177	Lung Cancer	Cancer	1	5	under $11k	0	16,483	11,302.1797	13,779.1953	14	black	19.898438	21	0.613892	0.29895	2	0	0	metastatic	0.99	0.9	no dnr	11	111	16.5	69	39	38.39844	176	null	null	0.899902	136	7.459961	182	17	1,874	1	0	no(M2 and SIP pres)	0
7,018	55.82498	1	female	1	6	6	Cirrhosis	COPD/CHF/Cirrhosis	3	12	under $11k	0	10,498	6,723.6055	7,964.65625	20	black	34.695313	56	0.504883	0.302979	1	1	0	no	0.8	0.6	no dnr	6	115	29.398438	189	10	38.79688	null	3.599609	0.899902	1.699951	141	null	241	87	1,929	null	0	<2 mo. follow-up	0
7,019	38.59799	1	female	0	25	44	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$25-$50k	0	53,366	37,353.7812	43,934.875	23	white	31.898438	83	0.725952	0.640991	9	0	0	no	0.8	0.5	no dnr	25	61	13.5	129	34	38.09375	172	1.5	2.599609	1.599854	136	7.299805	144	37	1,710	null	5	<2 mo. follow-up	5
7,020	68.36694	1	male	1	11	11	ARF/MOSF w/Sepsis	ARF/MOSF	2	7	$11-$25k	44	35,077	22,686.0156	28,511.875	48	white	35.5	77	0.336975	0.220978	1	0	0	no	0.8	0.7	dnr after sadm	11	123	10.099609	107	28	38.89844	262.5	2.5	0.599976	0.599976	145	7.429688	168	13	2,575	0	0	<2 mo. follow-up	0
7,021	66.5	1	male	0	16	133	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	null	44	29,556	19,580.9375	22,636.875	23	black	26.796875	40	0.594971	0.487	1	0	0	no	0.7	0.7	no dnr	16	64	5.299805	69	20	36.39844	null	4.299805	0.799927	3	142	null	86	45	3,900	null	0	no(M2 and SIP pres)	0
7,022	30.51599	1	female	1	6	6	Coma	Coma	0	12	null	0	37,150	23,628.5781	26,607.0156	72	white	31.5	48	0.735962	0.68689	4	0	0	no	0.7	0.8	no dnr	6	73	null	107	20	36.09375	197.125	4.199219	0.899902	1.399902	141	7.449219	89	27	1,475	null	0	<2 mo. follow-up	0
7,023	47.20297	1	male	1	11	11	ARF/MOSF w/Sepsis	ARF/MOSF	1	13	under $11k	44	17,934	11,697.0781	13,657.0391	27.5	white	27.898438	44	0.67688	0.581909	1	0	0	no	0.6	0.6	dnr after sadm	2	107	4.199219	138	28	39.39844	204	2.5	0.799927	1.199951	155	7.379883	113	22	2,130	null	7	<2 mo. follow-up	7
7,024	69.05396	1	female	1	15	15	CHF	COPD/CHF/Cirrhosis	5	12	$11-$25k	0	12,111	8,669	8,888.65625	12.333328	white	26.398438	39	0.704956	0.543945	1	1	0	yes	0.1	0.08	dnr after sadm	2	67	9.599609	91	34	38.39844	428.5625	2	0.599976	1.099854	133	7.399414	112	13	6,370	null	3	<2 mo. follow-up	3
7,025	39.03897	1	male	1	24	24	Cirrhosis	COPD/CHF/Cirrhosis	3	12	$11-$25k	0	98,885	0	0	59.666657	black	26.5	50	0.771973	0.636963	5	0	0	no	0.2	0.2	dnr after sadm	23	67	14	118	10	40.29688	185	2.599609	3.299805	1.599854	136	7.429688	78	36	2,261	null	1	<2 mo. follow-up	1
7,026	65.91095	1	male	0	7	10	Lung Cancer	Cancer	3	null	null	9	8,834	5,903.5859	7,766.14844	6.5	white	30.296875	36	0.311951	0.056	1	0	0	metastatic	0.4	0.5	no dnr	7	67	5.199219	98	20	35.5	null	2.699707	2.199707	2.599609	140	null	165	62	1,415	null	null	<2 mo. follow-up	4.546875
7,027	72.07098	1	male	1	44	44	ARF/MOSF w/Sepsis	ARF/MOSF	3	10	null	0	116,999	73,644.9375	85,335.9375	49.25	black	21.898438	39	0.730957	0.647949	4	0	0	yes	0.8	0.6	dnr after sadm	32	54	8.298828	29	16	36.09375	259.25	null	0.599976	3.099609	129	7.30957	158	69	1,575	null	6	<2 mo. follow-up	6
7,028	74.81696	1	male	1	7	7	Coma	Coma	2	12	$11-$25k	44	51,614	33,735.75	38,089.125	30	white	35.398438	86	0.040993	0.019997	12	0	0	no	0	0	dnr after sadm	4	61	4.699219	100	20	38	null	2.5	5.099609	1	135	null	176	31	900	null	5	<2 mo. follow-up	5
7,029	77.89697	1	male	0	40	100	ARF/MOSF w/Sepsis	ARF/MOSF	4	8	under $11k	0	78,090	51,049.0312	58,442.75	39	white	40.898438	77	0.250977	0.146973	1	1	0	yes	0.7	0.5	no dnr	40	143	0.069992	150	32	39.19531	124.28125	2.799805	3.399902	1.899902	139	7.349609	198	28	4,610	null	1	no(M2 and SIP pres)	1
7,030	52.94498	0	female	0	4	873	COPD	COPD/CHF/Cirrhosis	3	12	$25-$50k	0	3,607	2,301.6797	2,400.04883	20	white	29.796875	30	0.80896	0.690918	1	0	0	no	0.8	0.8	dnr after sadm	1	48	2.599609	105	12	38.09375	68	1.899902	1.799805	0.599976	136	7.419922	102	17	1,158	6	null	SIP>=30	4.527344
7,031	67.85797	0	male	0	24	872	ARF/MOSF w/Sepsis	ARF/MOSF	3	14	$25-$50k	0	39,652	26,462.3906	28,410.7656	23	white	17.597656	41	0.841919	0.78894	1	0	0	yes	0.8	0.8	no dnr	24	65	21.699219	129	28	35.39844	154	2.199707	1.199951	6.199219	138	7.429688	82	119	2,200	0	null	no(M2 and SIP pres)	0.494751
7,032	53.01797	0	female	0	7	871	MOSF w/Malig	ARF/MOSF	1	16	>$50k	0	7,959	5,581.6875	6,897.40625	19	white	29.898438	43	0.500977	0.382996	1	0	0	metastatic	0.8	0.6	no dnr	7	56	2.099609	110	20	36.5	null	2	10	0.699951	125	null	93	5	2,475	0	0	no(M2 and SIP pres)	0
7,033	61.43997	1	male	0	56	62	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	37	180,143	115,483.5	137,696.625	50.75	white	37.59375	80	0.269958	0.162994	1	0	0	yes	null	null	no dnr	56	57	12.5	74	11	36.79688	184	2.399902	2.399902	0.699951	137	7.479492	109	16	2,160	null	null	null	4.064453
7,034	58.20398	0	male	0	86	871	ARF/MOSF w/Sepsis	ARF/MOSF	2	14	$11-$25k	0	216,314	140,226.625	164,706.75	59	white	29.597656	68	0.68689	0.594971	1	0	0	yes	0.8	0.8	no dnr	86	114	6.199219	97	20	36.29688	null	3.899902	0.599976	1.199951	141	null	145	10	1,850	null	1	adl>=4 (>=5 if sur)	1
7,035	69.45697	1	female	0	8	706	COPD	COPD/CHF/Cirrhosis	0	8	under $11k	0	7,372	5,136.1484	5,995.13672	10.5	white	20.796875	29	0.833984	0.728882	1	0	0	no	0.9	0.7	no dnr	8	127	19	104	36	37.69531	297.125	2.799805	1	0.599976	136	7.399414	101	13	2,881	1	null	no(M2 and SIP pres)	1.166748
7,036	57.53299	1	female	0	7	223	COPD	COPD/CHF/Cirrhosis	3	12	under $11k	0	9,775	6,172.2305	6,936.95703	18.5	black	16.699219	29	0.917969	0.860962	1	0	0	no	0.9	0.95	no dnr	7	76	4.799805	73	16	36.09375	371.375	4.199219	1	1.199951	137	7.419922	106	23	1,220	1	2	no(M2 and SIP pres)	2
7,037	50.76797	1	female	1	3	3	ARF/MOSF w/Sepsis	ARF/MOSF	0	6	under $11k	0	16,143	9,824.7109	10,884.125	null	white	51.09375	74	0.22998	0.129974	1	0	0	no	0.1	0.1	no dnr	3	65	7.099609	107	24	36	100	3.299805	0.699951	2.5	137	7.369141	114	42	4,150	null	null	<2 mo. follow-up	2.187988
7,038	82.63898	1	female	1	4	4	Coma	Coma	1	7	under $11k	0	18,882	11,802.0625	14,196.7344	64	black	37.898438	87	0.145996	0.094986	1	0	0	no	0.01	0	dnr after sadm	2	66	7.5	96	28	38.09375	null	3.399902	1.599854	1.299805	144	null	81	12	5,872	null	null	<2 mo. follow-up	2.473145
7,039	39.04999	1	female	0	4	39	Cirrhosis	COPD/CHF/Cirrhosis	2	12	under $11k	0	3,991	2,759.334	3,354.55859	11	white	25.296875	38	0.824951	0.714966	1	0	0	no	0.8	0.8	no dnr	4	67	5.599609	58	16	36.29688	null	3.899902	1.199951	1.699951	131	null	179	38	1,580	0	0	<2 mo. follow-up	0
7,040	67.25299	1	male	0	11	24	Lung Cancer	Cancer	2	null	null	0	12,915	8,760.2344	12,108.2891	18	white	43.398438	52	0.048996	0.001	1	0	0	metastatic	0.5	0.2	dnr after sadm	5	129	10.199219	146	38	36.79688	436	null	null	1.299805	141	7.419922	119	27	820	null	null	<2 mo. follow-up	4.027344
7,041	63.99698	0	male	0	11	867	ARF/MOSF w/Sepsis	ARF/MOSF	0	8	$25-$50k	0	22,779	14,968.2656	17,315.8281	33	white	22.699219	37	0.827881	0.769897	1	0	0	no	0.5	0.6	no dnr	11	76	null	70	22	36.59375	null	null	null	1.099854	141	null	95	20	null	5	6	SIP>=30	6
7,042	53.21298	0	female	0	26	864	ARF/MOSF w/Sepsis	ARF/MOSF	0	8	under $11k	26	72,955	48,619.0938	54,370.5625	28	white	21.398438	14	0.778931	0.706909	6	0	0	no	0.8	0.8	no dnr	26	116	16.5	122	9	36.09375	172.5	3.099609	0.899902	0.699951	145	7.489258	267	18	3,717	null	0	null	0
7,043	41.67599	1	male	0	3	208	Lung Cancer	Cancer	3	10	under $11k	0	2,901	1,967.1094	2,331.83984	null	black	9.199219	5	0.863892	0.695923	1	0	0	metastatic	0.8	0.6	no dnr	3	74	12.298828	98	20	38.59375	null	2.099609	27.796875	1.099854	129	null	80	6	null	0	0	no(M2 and SIP pres)	0
7,044	62.15198	1	female	0	4	331	CHF	COPD/CHF/Cirrhosis	4	9	under $11k	0	4,001	2,693.3906	3,206.91992	14	white	18.796875	23	0.850952	0.753906	1	1	0	yes	0.99	0.85	no dnr	4	69	5.799805	111	8	37.69531	66	2.799805	0.899902	1	133	7.519531	132	18	2,585	0	1	no(M2 and SIP pres)	1
7,045	61.37198	1	male	1	4	4	Coma	Coma	0	17	under $11k	100	10,455	5,621.2656	7,498.19922	48	white	29.5	58	0.107986	0.065994	1	0	0	no	0.01	0.01	dnr after sadm	2	76	13.5	96	24	36.39844	null	1.699951	0.699951	2.299805	139	null	129	22	1,750	null	0	<2 mo. follow-up	0
7,046	78.74298	1	female	1	30	30	MOSF w/Malig	ARF/MOSF	1	9	$11-$25k	0	80,556	51,749.7812	70,531.0625	29.5	white	21.5	50	0.667969	0.570923	1	0	0	metastatic	0.1	0.01	no dnr	30	85	28.699219	64	20	37.69531	null	3.799805	0.699951	1	130	null	76	6	1,875	1	null	<2 mo. follow-up	1.166748
7,047	23.493	1	female	1	4	4	Coma	Coma	0	12	under $11k	100	13,030	8,057.0117	8,885.73438	53	white	87.5	87	0	0	1	0	0	no	0.01	0.01	dnr after sadm	2	69	16.199219	64	24	36.59375	319	null	null	0.599976	143	7.379883	90	11	null	null	0	<2 mo. follow-up	0
7,048	69.91895	0	male	0	9	859	COPD	COPD/CHF/Cirrhosis	2	5	$11-$25k	0	12,092	8,069.5352	8,337.34375	10.5	white	18	27	0.863892	0.774902	1	0	0	no	0.9	0.9	no dnr	9	106	22.199219	122	20	36.59375	507.375	2.099609	1.199951	0.899902	137	7.479492	203	17	2,800	0	0	no(M2 and SIP pres)	0
7,049	41.16599	1	male	0	15	66	ARF/MOSF w/Sepsis	ARF/MOSF	4	10	under $11k	9	34,917	24,943.7812	28,346.2188	19	black	27.296875	71	0.78894	0.718994	4	0	0	no	0.7	0.7	no dnr	15	174	7.599609	116	40	38.69531	263.3125	2.599609	0.5	0.599976	136	7.479492	368	15	1,807	1	0	null	0
7,050	41.29199	1	male	0	16	75	Colon Cancer	Cancer	1	12	under $11k	0	19,689	13,671.9922	15,415.2266	14.666664	white	15.898438	15	0.866943	0.702881	1	0	0	metastatic	0.5	0.2	no dnr	16	64	12.5	67	35	36.89844	250	null	null	0.699951	134	7.479492	191	22	2,258	5	1	SIP>=30	1
7,051	86.36298	0	female	0	30	857	COPD	COPD/CHF/Cirrhosis	3	12	under $11k	0	58,245	31,631.7969	38,247.9062	20.75	white	17.097656	20	0.770996	0.635986	2	0	0	no	0.8	0.7	dnr before sadm	-1	84	8.199219	79	32	39.09375	null	2.5	0.899902	0.899902	127	null	113	13	1,550	1	4	no(M2 and SIP pres)	4
7,052	68.36694	1	male	1	4	4	COPD	COPD/CHF/Cirrhosis	5	null	null	61	3,360	2,318.0449	2,758.04883	20	white	23.199219	45	0.437988	0.237	1	1	0	metastatic	null	null	dnr after sadm	1	105	6.5	99	28	35.69531	210	null	null	1.899902	126	7.239258	115	38	1,893	null	null	<2 mo. follow-up	5.375
7,053	55.047	0	male	0	58	857	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$25-$50k	0	156,289	106,187.125	111,966.688	47	white	23.097656	32	0.787964	0.718994	34	0	0	no	0.85	0.85	no dnr	58	111	16.199219	136	12	35.89844	130	2	0.599976	1.899902	133	7.379883	73	61	2,790	null	0	SIP>=30	0
7,054	77.91394	0	female	0	13	856	MOSF w/Malig	ARF/MOSF	1	14	under $11k	9	27,049	18,148.6719	20,320.8594	30	black	21.097656	37	0.619995	0.514893	2	0	0	metastatic	0.85	0.85	no dnr	13	133	22.097656	141	42	36.69531	186.65625	3.299805	0.599976	0.699951	125	7.399414	159	16	1,316	0	1	no(M2 and SIP pres)	1
7,055	75.05499	1	male	1	33	33	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	null	26	82,102	51,896.9375	60,446.4688	48.25	white	26	29	0.640991	0.539917	1	0	0	no	0.8	0.7	no dnr	33	125	25.796875	131	26	36.69531	400	2.199707	5.199219	2.599609	146	7.299805	191	87	4,825	null	5	<2 mo. follow-up	5
7,056	58.82498	0	female	0	20	853	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	under $11k	0	44,069	28,972.2031	34,253.4688	35.333313	white	32.09375	76	0.691895	0.600952	1	0	0	no	0.7	0.9	no dnr	20	61	18.199219	108	10	39	234	null	null	0.599976	137	7.519531	116	9	3,299	null	5	null	5
7,057	76.61298	1	male	0	6	57	CHF	COPD/CHF/Cirrhosis	3	11	under $11k	0	5,398	3,957.8242	3,586.74805	17	white	23.296875	45	0.777954	0.645996	1	1	0	no	0.75	0.5	no dnr	6	109	1.699951	63	20	35.5	null	2.5	0.5	1.599854	130	null	157	14	700	1	null	<2 mo. follow-up	1.166748
7,058	44.05499	1	male	0	9	602	CHF	COPD/CHF/Cirrhosis	2	12	under $11k	0	7,828	5,585.0234	7,064.72656	8.5	white	12	0	0.951904	0.918945	1	0	0	no	1	0.95	no dnr	9	73	16.898438	70	16	35.89844	112.23438	3.099609	0.599976	1.199951	129	7.479492	415	28	2,500	0	null	no(M2 and SIP pres)	0.494751
7,059	73.79895	0	female	0	9	849	CHF	COPD/CHF/Cirrhosis	3	null	under $11k	0	12,704	7,072.0625	8,324.51562	12.5	white	16.699219	31	0.870972	0.785889	1	0	0	no	0.9	0.7	no dnr	9	73	8.798828	76	20	36.19531	342.8125	2	1.699951	0.799927	133	7.429688	127	20	2,730	2	0	no(M2 and SIP pres)	0
7,060	60.04898	1	female	0	7	14	COPD	COPD/CHF/Cirrhosis	2	12	under $11k	0	5,874	4,007.1875	5,133.14844	8	white	25.398438	22	0.825928	0.716919	1	0	0	no	0.8	0.6	no dnr	7	73	12.599609	114	26	38.5	null	2.299805	3.599609	0.699951	134	null	96	17	1,840	3	5	<2 mo. follow-up	5
7,061	34.59299	0	male	0	9	849	COPD	COPD/CHF/Cirrhosis	4	11	under $11k	0	10,607	7,043.9961	8,404.83594	11.5	black	19.5	23	0.951904	0.918945	1	0	0	no	1	1	no dnr	9	61	6.599609	63	10	36.29688	195	3.399902	0.599976	0.799927	140	7.129883	124	9	2,067	1	null	null	1.166748
7,062	60.81299	0	male	0	51	847	ARF/MOSF w/Sepsis	ARF/MOSF	1	10	$25-$50k	0	139,666	90,593.75	106,514.5	57.25	white	36.09375	72	0.589966	0.480957	1	0	0	no	0.75	0.75	no dnr	51	64	13.798828	100	26	39	136	2.399902	0.799927	1.299805	134	7.529297	211	9	4,660	null	7	adl>=4 (>=5 if sur)	7
7,063	38.78198	0	male	0	3	846	Cirrhosis	COPD/CHF/Cirrhosis	2	11	under $11k	0	2,783	1,907.6865	2,221.56836	null	white	18.398438	13	0.896973	0.826904	1	0	0	no	1	0.95	no dnr	3	110	13.199219	122	24	38.79688	null	4.599609	1	1.199951	132	null	159	6	1,250	0	null	null	0.494751
7,064	63.228	1	male	1	6	6	MOSF w/Malig	ARF/MOSF	1	12	under $11k	9	13,880	9,691.0312	12,533.3828	15	white	41	72	0.122986	0.054993	8	0	0	yes	0.2	0.1	dnr after sadm	2	95	7.799805	110	22	38.69531	251.40625	null	null	1.5	132	7.399414	193	17	1,210	null	1	<2 mo. follow-up	1
7,065	38.69397	0	male	0	56	845	ARF/MOSF w/Sepsis	ARF/MOSF	0	11	under $11k	37	105,673	71,900.75	79,940.25	36.75	white	24	42	0.759888	0.682983	6	0	0	no	0.7	0.7	no dnr	56	101	6.5	170	28	36.69531	null	2.899902	20.898438	0.399963	132	null	327	15	null	null	2	no(M2 and SIP pres)	2
7,066	57.599	0	male	0	14	845	ARF/MOSF w/Sepsis	ARF/MOSF	2	9	null	0	23,119	15,648.1562	16,925.1094	19.333328	hispanic	19.898438	39	0.875	0.830933	1	0	0	no	0.95	0.95	no dnr	14	78	27.898438	120	10	35.5	595.125	1.599854	0.399963	3.699707	135	7.449219	89	40	0	null	0	no(M2 and SIP pres)	0
7,067	69.67798	1	male	0	3	750	CHF	COPD/CHF/Cirrhosis	3	12	$11-$25k	0	1,684	1,282.1348	1,205.17969	null	white	18.5	20	0.863892	0.775879	1	0	0	no	0.8	0.8	no dnr	3	60	15.599609	122	52	38.09375	140	1.899902	1.199951	4.899414	138	7.389648	160	37	526	6	6	no(M2 and SIP pres)	6
7,068	57.04898	1	male	1	19	19	Coma	Coma	0	8	under $11k	0	56,392	36,381.0312	42,558.75	57.333313	white	24.296875	31	0.735962	0.68689	1	0	0	no	0.3	0.2	dnr after sadm	17	138	26.796875	72	24	35	390.4375	2	5.299805	1.399902	152	7.40918	173	20	2,800	null	0	<2 mo. follow-up	0
7,069	76.66498	1	male	0	20	278	ARF/MOSF w/Sepsis	ARF/MOSF	3	9	null	0	43,677	29,397.1719	32,307.4062	30.333328	white	25.296875	33	0.68396	0.589966	7	1	0	no	0.8	0.8	no dnr	20	128	28.097656	147	0	38.5	163.25	null	null	0.599976	134	7.379883	101	13	3,000	null	3	no(M2 and SIP pres)	3
7,070	56.95798	1	male	0	38	674	ARF/MOSF w/Sepsis	ARF/MOSF	3	null	under $11k	9	43,875	30,696.6875	35,997.125	13.5	black	25.296875	21	0.778931	0.706909	2	0	0	no	0.8	0.5	no dnr	38	106	15.199219	121	32	37.79688	325	2.699707	1.299805	1.799805	161	7.329102	98	24	3,150	null	1	no(M2 and SIP pres)	1
7,071	68.94696	1	male	0	17	58	MOSF w/Malig	ARF/MOSF	2	8	under $11k	0	22,022	15,748.1641	21,591.625	17.333328	black	18.097656	29	0.708984	0.620972	4	0	0	metastatic	0.9	0.8	no dnr	17	109	11.099609	100	32	35.19531	null	3	1.199951	1.199951	134	null	197	21	300	3	2	<2 mo. follow-up	2
7,072	70.02899	0	female	0	6	839	CHF	COPD/CHF/Cirrhosis	3	12	under $11k	0	5,310	3,739.8125	4,027.36914	8	white	10.699219	19	0.924927	0.872925	1	1	0	no	0.95	0.9	no dnr	6	125	6	120	8	38.19531	205.6875	1.399902	5	0.699951	129	7.539062	163	21	2,174	0	0	no(M2 and SIP pres)	0
7,073	39.29898	0	male	0	4	837	Cirrhosis	COPD/CHF/Cirrhosis	4	8	under $11k	0	8,162	5,345.1914	6,326.28906	15	white	19.699219	18	0.875	0.791992	2	0	0	no	0.2	0.05	no dnr	4	66	13.099609	48	20	34.79688	null	2.799805	0.299988	1.699951	138	null	83	32	null	0	0	no(M2 and SIP pres)	0
7,074	63.13998	1	male	0	9	752	COPD	COPD/CHF/Cirrhosis	4	11	under $11k	0	8,050	5,557.668	6,649.9375	9	white	26.597656	36	0.791992	0.664917	1	1	0	no	1	1	no dnr	9	69	14	75	22	37.79688	142.5	2	1.199951	1.299805	132	7.509766	511	32	5,660	3	null	SIP>=30	2.510742
7,075	65.69196	1	male	0	25	253	ARF/MOSF w/Sepsis	ARF/MOSF	2	18	null	0	54,606	36,313.7812	40,016.8125	24.25	white	21.296875	30	0.768921	0.694946	4	0	0	yes	0.75	0.6	no dnr	25	53	13.5	114	12	35.39844	226.65625	1.799805	4.099609	2.5	134	7.419922	194	30	362	null	0	no(M2 and SIP pres)	0
7,076	58.23398	1	female	0	46	626	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	null	0	147,887	91,126.9375	104,032.562	33.75	white	24.898438	48	0.723999	0.638916	6	1	0	yes	0.4	0.2	no dnr	46	53	16.296875	63	10	35	132	2.299805	0.599976	8.199219	125	7.299805	152	124	290	null	0	no(M2 and SIP pres)	0
7,077	76.22998	1	female	1	5	5	Coma	Coma	1	11	$11-$25k	94	10,842	6,858.332	8,003.27734	31	white	26.5	40	0.087997	0.050995	1	0	0	no	0	0	dnr after sadm	2	61	16.398438	72	22	36.29688	107.5	2.699707	0.399963	0.599976	139	7.379883	155	12	1,615	null	7	<2 mo. follow-up	7
7,078	34.49399	0	female	0	9	836	ARF/MOSF w/Sepsis	ARF/MOSF	1	10	under $11k	0	21,510	13,542.9688	15,778.5	22.5	black	29.796875	31	0.826904	0.767944	1	0	0	no	0.9	0.9	no dnr	9	72	11.099609	96	24	38.89844	303.6875	2.199707	0.899902	1	133	7.489258	114	21	3.519531	null	0	no(M2 and SIP pres)	0
7,079	72.62097	1	female	1	9	9	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	under $11k	0	93,984	60,547.6562	74,304.75	64	white	38	71	0.34198	0.225983	16	0	0	no	0.3	0.3	no dnr	9	64	0.399963	126	20	38.89844	null	null	null	1.599854	135	null	180	12	4,400	null	1	<2 mo. follow-up	1
7,080	83.66595	1	male	1	23	23	Coma	Coma	3	null	null	0	76,277	44,498.9062	53,890.25	27.666656	white	23.597656	58	0.437988	0.363953	11	0	0	no	0.01	0.01	dnr after sadm	21	68	19	140	40	38.59375	150	3	8	2.099609	136	7.399414	96	94	4,435	null	0	<2 mo. follow-up	0
7,081	65.71698	1	female	1	41	41	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	under $11k	0	152,366	107,529.938	124,863	58.5	white	35.195313	49	0.50293	0.385986	7	0	0	no	0.6	0.6	dnr after sadm	41	55	14.398438	107	13	37.69531	154	1.399902	1.199951	1.599854	136	7.349609	402	46	1,577	null	0	<2 mo. follow-up	0
7,082	57.88098	1	female	1	103	103	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	under $11k	0	231,688	148,618.375	171,990.625	42.25	white	28.398438	28	0.748901	0.669922	2	0	0	no	0.5	0.1	dnr after sadm	92	83	11.5	110	20	36.59375	268	3.399902	0.599976	0.899902	149	7.419922	113	21	550	0	1	SIP>=30	1
7,083	55.784	1	male	0	9	130	Lung Cancer	Cancer	3	9	$11-$25k	0	9,178	6,278.0234	8,268.85938	14	white	30.097656	22	0.399963	0.102997	1	0	0	metastatic	0.6	0.4	no dnr	9	146	null	71	39	36.5	165	4.199219	1.5	0.899902	143	7.339844	135	14	4,078	1	1	no(M2 and SIP pres)	1
7,084	23.452	0	male	0	6	832	ARF/MOSF w/Sepsis	ARF/MOSF	3	10	under $11k	0	8,584	5,815.5508	6,852.29688	38	hispanic	22.597656	43	0.917969	0.887939	1	1	0	no	0.95	0.9	no dnr	6	38	27.097656	138	38	35.39844	39	2.899902	1.099854	1.199951	134	7.319336	393	16	851	1	null	SIP>=30	1.166748
7,085	62.77298	0	male	0	22	831	ARF/MOSF w/Sepsis	ARF/MOSF	2	16	under $11k	0	35,988	22,787.0312	26,705.5781	21.333328	white	23.597656	32	0.819946	0.758911	1	0	0	no	0.6	0.6	no dnr	22	58	39.09375	130	10	39.69531	180	2.5	4.199219	4	147	7.399414	236	65	83	null	null	SIP>=30	2.598633
7,086	60.94699	1	male	0	9	21	Lung Cancer	Cancer	2	3	under $11k	0	10,915	7,250.5625	9,002.85938	15	white	24.296875	18	0.547974	0.224976	1	0	0	metastatic	0.6	0.5	no dnr	9	70	2.399902	104	20	37.59375	null	2.299805	7	0.5	133	null	78	2	950	2	4	<2 mo. follow-up	4
7,087	66.5	1	male	0	3	269	Lung Cancer	Cancer	1	14	$25-$50k	0	3,819	2,507.5723	2,884.60938	13	white	10.599609	6	0.812988	0.5979	1	0	0	metastatic	0.7	0.5	no dnr	3	56	4.699219	101	20	34.5	null	2.399902	5.399414	0.799927	131	null	139	9	675	2	null	no(M2 and SIP pres)	1.838867
7,088	59.57797	0	female	0	9	829	ARF/MOSF w/Sepsis	ARF/MOSF	1	11	under $11k	0	27,295	17,937.1875	19,045.1719	25	white	28.898438	25	0.564941	0.452942	5	0	0	metastatic	0.5	0.4	no dnr	9	133	11.798828	100	10	35	257.125	2.399902	0.399963	1.5	142	7.439453	82	40	5,210	6	6	no(M2 and SIP pres)	6
7,089	81.55194	0	female	0	3	828	COPD	COPD/CHF/Cirrhosis	3	7	under $11k	0	4,090	2,069.9492	2,634.22852	null	white	14.099609	28	0.851929	0.755981	1	0	0	no	null	null	no dnr	3	126	10.798828	67	22	38.09375	185	4	1.099854	0.5	133	7.379883	105	7	3,980	1	1	no(M2 and SIP pres)	1
7,090	44.35599	1	male	1	4	4	ARF/MOSF w/Sepsis	ARF/MOSF	2	9	under $11k	100	14,176	8,502.6875	9,937.72656	63	white	62.195313	129	0	0	1	0	0	no	0	0	dnr after sadm	4	89	3.599609	60	20	37	null	4	0.399963	1.199951	136	null	122	9	null	null	5	<2 mo. follow-up	5
7,091	88.77997	1	male	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$11-$25k	44	22,140	14,377.9844	16,881.2812	59	white	22.898438	39	0.500977	0.383972	4	0	0	no	null	null	no dnr	5	70	7.199219	114	16	36.39844	292	null	null	1.199951	139	7.40918	198	18	1,590	null	5	<2 mo. follow-up	5
7,092	73.37695	1	male	1	21	21	Coma	Coma	4	null	null	41	38,297	24,944.0625	29,027.75	35	black	22.097656	42	0.47998	0.407959	1	0	1	no	1	0.5	dnr after sadm	19	49	11.398438	60	18	39.89844	156	2.799805	1.799805	1.299805	137	7.129883	216	23	1,554	null	null	<2 mo. follow-up	5.647461
7,093	74.64996	1	male	0	14	36	MOSF w/Malig	ARF/MOSF	1	11	null	0	15,429	10,809.7266	15,069.8984	13.666664	white	29.398438	42	0.529907	0.41394	2	0	0	yes	0.8	0.6	dnr after sadm	1	101	41.796875	74	28	35.89844	219.03125	3.699707	2.399902	0.899902	137	7.519531	97	33	null	0	0	<2 mo. follow-up	0
7,094	82.41998	0	male	0	20	823	ARF/MOSF w/Sepsis	ARF/MOSF	2	20	$25-$50k	0	35,216	24,531.2031	27,599.6094	22	white	21.398438	36	0.665894	0.56897	9	0	0	yes	0.65	0.55	no dnr	20	0	14.699219	0	16	37.69531	55	1.699951	0.599976	2.899902	121	7.269531	257	38	null	0	null	adl>=4 (>=5 if sur)	0.494751
7,095	71.48297	1	female	0	11	93	Colon Cancer	Cancer	1	12	under $11k	9	8,207	6,213.6523	7,953.60938	8	hispanic	28.597656	19	0.530884	0.208984	1	0	0	metastatic	0.8	0.5	dnr after sadm	7	115	6.399414	114	24	36.69531	216	3.699707	0.599976	1.099854	134	7.349609	103	17	1,325	null	0	adl>=4 (>=5 if sur)	0
7,096	63.25299	0	male	0	30	823	Coma	Coma	1	12	null	61	44,181	25,202.3906	31,573.2812	23.5	white	14.5	14	0.672974	0.615967	1	0	0	no	0.05	0	no dnr	30	57	8.699219	109	36	36.19531	173.46875	2.199707	0.599976	12.199219	136	7.379883	115	83	0	null	0	no(M2 and SIP pres)	0
7,097	69.82898	1	male	0	3	225	Lung Cancer	Cancer	2	12	$11-$25k	0	2,899	1,931.8603	2,303.25977	8	white	12.5	9	0.778931	0.537964	1	0	0	metastatic	0.9	0.5	no dnr	3	105	4.099609	71	28	37	null	null	null	0.799927	136	null	79	9	null	null	null	no(M2 and SIP pres)	2.416504
7,098	76.04895	0	female	0	8	822	CHF	COPD/CHF/Cirrhosis	5	13	under $11k	0	9,818	5,800.0547	7,187.97656	10.5	white	21.898438	44	0.800903	0.678955	1	1	0	no	0.9	0.85	dnr after sadm	2	114	15	69	26	38.69531	304.125	null	null	1.199951	134	7.40918	109	18	2,335	7	5	no(M2 and SIP pres)	5
7,099	68.28198	1	female	0	10	228	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	$11-$25k	41	22,189	14,281.4219	16,558.2344	35	white	32.796875	51	0.431946	0.311951	1	1	0	no	0.35	0.25	no dnr	10	114	19.597656	140	28	37.59375	240	2.799805	1.699951	1.5	144	7.119141	199	49	null	null	2	no(M2 and SIP pres)	2
7,100	64.22198	1	female	0	28	173	CHF	COPD/CHF/Cirrhosis	7	12	null	9	34,293	22,793.4844	25,882	22.5	white	24.699219	43	0.782959	0.652954	1	1	0	no	0.9	0.8	dnr after sadm	8	109	43.59375	128	8	36.89844	290	1.399902	1.899902	0.799927	135	7.449219	174	18	3,067	0	1	no(M2 and SIP pres)	1

Subsets and Splits

No community queries yet

The top public SQL queries from the community will appear here once available.